Supported by the Australian Trade and Investment Commission (Austrade) and Victorian Government, GZHT Technology, the Party Committee of Guanlan Street’s Life and Health Industry Chain and BIOGBA as well as organised by the Silver Star Group and Guangzhou International Bio Island, George Clinical will work with 360biolabs, Nucleus Network and Acclime to empower the international development of Chinese Life Science Companies into Australia.

Zhenfei Yin, George Clinical’s Head, Project Operations, China, will share the experience and challenges of multi-center clinical trial development and how to use the advantages of Australian clinical trials to empower Chinese pharmaceutical companies to go overseas to conduct their clinical trials.

To schedule a time to meet or learn more about how George Clinical can help support your study, please contact our Head of Business Development, APAC Fred Li.